Elevance Health, Inc.
0HG8.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$114.59B
Close$
$755.39
78.1% upside
Current Fair Value
78.1% upsideUndervalued by 78.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $114.59 Billion |
|---|---|
| Enterprise Value | $104.74 Billion |
| Dividend Yield | $6.87 (1.66%) |
| Earnings per Share | $25.28 |
| Beta | 0.69 |
| Outstanding Shares | 217,900,000 |
Return
| Return on Equity | 11.02% |
|---|---|
| Return on Assets | 3.91% |
| Return on Invested Capital | 144.14% |
Valuation & Multiples
| P/E Ratio | 18.34 |
|---|---|
| PEG | -50.71 |
| Price to Sales | 0.46 |
| Price to Book Ratio | 2.06 |
| Enterprise Value to Revenue | 0.52 |
| Enterprise Value to EBIT | 0.88 |
| Enterprise Value to Net Income | 21 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 15, 2026
EPS Estimate
$6.21
Average shareholder expectationRevenue Estimate
$48.88 B
Average shareholder expectationNext Earnings Call
Expected Date
October 21, 2026
EPS Estimate
$4.70
Average shareholder expectationRevenue Estimate
$49.29 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Anthem Inc
97,100 employees
CEO: Gail Boudreaux Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a va...